13.11.2018 - 15.11.2018Hilton Boston Logan Airport, 1 Hotel Drive, 02128 Boston, USA
Time: 08:00 to 17:00
Conference themes "Optimize complex discovery, biomarker validation and clinical translation to develop complement inhibition for rare and common diseases"
With the only approved complement therapeutic, Soliris, on the market for over a decade, the industry is overflowing with companies in clinical translation in a race for the next approval.
Speakers: Mark Ma, Senior Director, Bioanalytical and Biomarker Development, Alexion Research, Mingjun Huang, Senior Vice President and Head of Research, Achillion Pharmaceuticals, and more.